Cargando…

Synergistic Inhibitory Effect of Hyperbaric Oxygen Combined with Sorafenib on Hepatoma Cells

OBJECTIVES: Hypoxia is a common phenomenon in solid tumors, associated with chemotherapy and radiotherapy resistance, recurrence and metastasis. Hyperbaric oxygen (HBO) therapy can increase tissue oxygen pressure and content to prevent the resistance, recurrence and metastasis of cancer. Presently,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Hai-Shan, Liao, Ming-Bin, Zhang, Mei-Yin, Xie, Yin, Xu, Li, Zhang, Yao-Jun, Zheng, X. F. Steven, Wang, Hui-Yun, Chen, Yi-Fei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067386/ https://www.ncbi.nlm.nih.gov/pubmed/24956259 http://dx.doi.org/10.1371/journal.pone.0100814

Ejemplares similares

Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells
por: Cao, J.Y., et al.
Publicado: (2017)

hGC33-Modified and Sorafenib-Loaded Nanoparticles have a Synergistic Anti-Hepatoma Effect by Inhibiting Wnt Signaling Pathway
por: Shen, Jing, et al.
Publicado: (2020)

The Inhibitory Effects of Recombinant Hespintor Combined with Sorafenib on Transplanted Human Hepatoma in Nude Mice, and Transcriptional Regulation of Hespintor Based on RNA-Seq
por: Lun, Yong-Zhi, et al.
Publicado: (2021)

Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling
por: Wan, J, et al.
Publicado: (2013)

New scientific definitions: hyperbaric therapy and hyperbaric oxygen therapy
por: Harch, Paul G.
Publicado: (2022)

Cyclin-dependent kinase inhibitor 2B gene is associated with the sensitivity of hepatoma cells to Sorafenib
por: Weng, Xie, et al.
Publicado: (2019)

Hyperbaric Oxygen Therapy in Liver Diseases
por: Sun, Yun, et al.
Publicado: (2018)

An overview of hyperbaric oxygen preconditioning against ischemic stroke
por: Wu, Xuyi, et al.
Publicado: (2023)

Overexpression of c-Jun contributes to sorafenib resistance in human hepatoma cell lines
por: Haga, Yuki, et al.
Publicado: (2017)

Hyperbaric oxygen for stroke treatment
por: Toole, James
Publicado: (2011)

Hyperbaric oxygen and wound healing
por: Bhutani, Sourabh, et al.
Publicado: (2012)

Hyperbaric oxygen therapy in China
por: Yan, Ling, et al.
Publicado: (2015)

Editorial: Hyperbaric oxygen and the brain
por: Hadanny, Amir, et al.
Publicado: (2022)

Hyperbaric oxygen and topical oxygen are different treatments
por: Handan, Ozturk, et al.
Publicado: (2015)

α‐Fetoprotein fragment synergizes with sorafenib to inhibit hepatoma cell growth and migration and promote the apoptosis
por: Wang, Qiujiao, et al.
Publicado: (2022)

INHIBITORY EFFECT OF CHITOSAN OLIGOSACCHARIDE ON HUMAN HEPATOMA CELLS IN VITRO
por: Liu, Likun, et al.
Publicado: (2017)

Effect of hyperbaric oxygen on post-stroke depression
por: Guo, Hong, et al.
Publicado: (2023)

Child–Pugh Score and ABCG2-rs2231142 Genotype Independently Predict Survival in Advanced Hepatoma Patients Treated with Sorafenib
por: Huang, Po-Han, et al.
Publicado: (2022)

Hyperbaric Oxygen Improves the Survival and Angiogenesis of Fat Grafts after Autologous Fat Transplantation
por: Liu, Fei, et al.
Publicado: (2022)

Hybrid Lipid Nanoformulations for Hepatoma Therapy: Sorafenib Loaded Nanoliposomes—A Preliminary Study
por: Bartos, Adrian, et al.
Publicado: (2022)

Hyperbaric oxygen treatment on keloid tumor immune gene expression
por: Wang, Chun-Hu, et al.
Publicado: (2021)

Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
por: Cheng, Yang, et al.
Publicado: (2017)

Application of hyperbaric oxygen in liver transplantation
por: Lv, Hu, et al.
Publicado: (2016)

Hyperbaric oxygen therapy in Fournier’s gangrene
por: de Bessa, José
Publicado: (2022)

Reaction of the Hippocampal Microglia to Hyperbaric Oxygen
por: Kirik, O. V., et al.
Publicado: (2022)

Inhibition of pMAPK14 Overcomes Resistance to Sorafenib in Hepatoma Cells with Hepatitis B Virus()
por: Witt-Kehati, Dvora, et al.
Publicado: (2018)

Porphyrin Based 2D-MOF Structures as Dual-Kinetic Sorafenib Nanocarriers for Hepatoma Treatment
por: Bieniek, Adam, et al.
Publicado: (2021)

Ginsenoside Rg3 in combination with artesunate overcomes sorafenib resistance in hepatoma cell and mouse models
por: Chen, Ying-Jie, et al.
Publicado: (2022)

Synergistic Effect of Sorafenib and Radiation on Human Oral Carcinoma in vivo
por: Hsu, Fei-Ting, et al.
Publicado: (2015)

Hyperbaric oxygen preconditioning: a reliable option for neuroprotection
por: Hu, Qin, et al.
Publicado: (2016)

Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
por: Yang, Qu, et al.
Publicado: (2021)

Inhibitory Effect of Sarcophytol A on Development of Spontaneous Hepatomas in Mice
por: Yamauchi, Osamu, et al.
Publicado: (1991)

The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation.
por: Brizel, D. M., et al.
Publicado: (1995)

Synergistic effect of resveratrol and HSV-TK/GCV therapy on murine hepatoma cells
por: Xiao, Jianyong, et al.
Publicado: (2018)

Hyperbaric oxygen therapy for traumatic brain injury
por: Huang, Lei, et al.
Publicado: (2011)

Effects of hyperbaric oxygenation therapy on symptomatic pneumocephalus
por: Paiva, Wellingson Silva, et al.
Publicado: (2014)

Hyperbaric Oxygen for Osteomyelitis in a Compromised Host
por: Delasotta, Lawrence A, et al.
Publicado: (2013)

Hyperbaric oxygen treatment in autism spectrum disorders
por: Rossignol, Daniel A, et al.
Publicado: (2012)

Hyperbaric oxygen therapy and cancer—a review
por: Moen, Ingrid, et al.
Publicado: (2012)

Successful treatment of frostbite with hyperbaric oxygen treatment
por: Dwivedi, Deepak A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ag19j0knggur3pt7hi8sob2ekn